Related Experiment Video
Updated: Jun 20, 2026

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
Published on: May 26, 2023
Risk factors for bleeding in pediatric post-cardiotomy patients requiring ECLS
Kathryn Nardell1, Gail M Annich, Jennifer C Hirsch
1Departments of Pediatric (Cardiology), University of Michigan Health Systems, Ann Arbor, MI, USA.
Pediatric patients on extracorporeal life support (ECLS) experience most bleeding early. Longer cardiopulmonary bypass (CPB) time and low platelets increase early bleeding risk in these post-cardiotomy patients.
Area of Science:
- Pediatric Cardiac Surgery
- Extracorporeal Life Support
- Hemostasis and Thrombosis
Background:
- Limited literature exists on bleeding patterns in pediatric post-cardiotomy patients requiring extracorporeal life support (ECLS).
- Understanding bleeding complications is crucial for managing these high-risk patients.
Purpose of the Study:
- To retrospectively review bleeding complications in pediatric post-cardiotomy patients on ECLS.
- To identify risk factors associated with excessive bleeding in this population.
Main Methods:
- Retrospective review of 145 pediatric patient records.
- Classification of patients into excessive (E) and non-excessive (NE) bleeding groups based on blood loss.
- Analysis of bleeding patterns and associated clinical factors.
Main Results:
- Excessive bleeding predominantly occurred within the first 0-6 hours post-ECLS.
- Longer cardiopulmonary bypass (CPB) duration and lower platelet counts were significantly associated with increased bleeding in the first 6 hours (p=0.005).
- Intraoperative protamine use with normal platelets correlated with reduced bleeding between 7-12 hours post-ECLS (p=0.002).
Conclusions:
- The majority of bleeding in pediatric post-cardiotomy patients on ECLS happens early after support initiation.
- Longer CPB time and thrombocytopenia are key risk factors for early post-ECLS bleeding.
- Strategies to minimize bleeding include protamine administration, aggressive blood product replacement targeting 100-120K platelets, and timely surgical exploration if needed.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiac Catheterization IV: Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Varices-I: Introduction
